Dr Reddy's Laboratories Ltd
F:RDDA
Dr Reddy's Laboratories Ltd
F:RDDA
Price:
11.7
EUR
1.74%
Market Closed
Market Cap:
€1.9B
Cash Flow Statement
Cash Flow Statement
Dr Reddy's Laboratories Ltd
Dr Reddy's Laboratories Ltd
Currency: INR
| Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||
| Net Income |
18 857
|
20 037
|
28 835
|
29 384
|
30 614
|
43 147
|
60 485
|
67 336
|
72 010
|
72 343
|
76 795
|
75 293
|
|
| Depreciation & Amortization |
11 631
|
11 698
|
12 288
|
11 980
|
11 652
|
11 982
|
12 502
|
13 680
|
14 700
|
15 188
|
17 037
|
19 068
|
|
| Stock-Based Compensation |
615
|
0
|
741
|
0
|
740
|
0
|
644
|
0
|
821
|
0
|
796
|
0
|
|
| Other Non-Cash Items |
13 994
|
12 404
|
8 584
|
7 023
|
7 102
|
7 048
|
4 457
|
2 722
|
(1 048)
|
2 395
|
2 578
|
3 455
|
|
| Cash Taxes Paid |
7 105
|
5 518
|
5 716
|
7 178
|
7 437
|
8 538
|
10 714
|
14 560
|
20 047
|
20 315
|
19 993
|
20 084
|
|
| Cash Interest Paid |
1 608
|
1 328
|
1 321
|
1 378
|
1 345
|
1 601
|
1 853
|
2 032
|
2 266
|
2 896
|
3 483
|
4 067
|
|
| Change in Working Capital |
(14 641)
|
(14 070)
|
(14 004)
|
(31 193)
|
(21 260)
|
(19 791)
|
(18 569)
|
(11 623)
|
(40 229)
|
(55 858)
|
(49 982)
|
(38 995)
|
|
| Cash from Operating Activities |
29 841
N/A
|
30 069
+1%
|
35 703
+19%
|
17 194
-52%
|
28 108
+63%
|
42 386
+51%
|
58 875
+39%
|
72 115
+22%
|
45 433
-37%
|
34 068
-25%
|
46 428
+36%
|
58 821
+27%
|
|
| Investing Cash Flow | |||||||||||||
| Capital Expenditures |
(6 115)
|
(8 043)
|
(12 561)
|
(18 543)
|
(19 049)
|
(20 520)
|
(18 866)
|
(22 957)
|
(27 435)
|
(25 658)
|
(34 398)
|
(40 349)
|
|
| Other Items |
1 192
|
(8 958)
|
(10 099)
|
11 215
|
(7 338)
|
(3 419)
|
(22 507)
|
(31 979)
|
(12 848)
|
(41 191)
|
(23 679)
|
(7 146)
|
|
| Cash from Investing Activities |
(4 923)
N/A
|
(17 001)
-245%
|
(22 660)
-33%
|
(7 328)
+68%
|
(26 387)
-260%
|
(23 939)
+9%
|
(41 373)
-73%
|
(54 936)
-33%
|
(40 283)
+27%
|
(66 849)
-66%
|
(58 077)
+13%
|
(47 495)
+18%
|
|
| Financing Cash Flow | |||||||||||||
| Net Issuance of Common Stock |
(470)
|
(9)
|
(924)
|
(630)
|
334
|
119
|
368
|
1 067
|
805
|
197
|
(1 196)
|
(1 065)
|
|
| Net Issuance of Debt |
(19 165)
|
(6 766)
|
6 094
|
2 289
|
2 735
|
(14 156)
|
(20 397)
|
(4 614)
|
4 346
|
32 745
|
23 196
|
(1 515)
|
|
| Cash Paid for Dividends |
(3 916)
|
(4 147)
|
(4 147)
|
(4 146)
|
(4 146)
|
(4 979)
|
(4 979)
|
(6 648)
|
(6 648)
|
(6 662)
|
(6 662)
|
(6 659)
|
|
| Other |
(1 608)
|
(1 328)
|
(1 321)
|
(1 378)
|
(1 345)
|
(1 601)
|
(1 853)
|
(2 032)
|
(2 266)
|
4 160
|
3 573
|
(4 067)
|
|
| Cash from Financing Activities |
(25 159)
N/A
|
(12 250)
+51%
|
(298)
+98%
|
(3 865)
-1 197%
|
(2 422)
+37%
|
(20 617)
-751%
|
(26 861)
-30%
|
(12 227)
+54%
|
(3 763)
+69%
|
30 440
N/A
|
18 911
-38%
|
(13 306)
N/A
|
|
| Change in Cash | |||||||||||||
| Effect of Foreign Exchange Rates |
(25)
|
(38)
|
113
|
191
|
733
|
1 283
|
286
|
(510)
|
(59)
|
90
|
224
|
602
|
|
| Net Change in Cash |
(266)
N/A
|
780
N/A
|
12 858
+1 548%
|
6 192
-52%
|
32
-99%
|
(887)
N/A
|
(9 073)
-923%
|
4 442
N/A
|
1 328
-70%
|
(2 251)
N/A
|
7 486
N/A
|
(1 378)
N/A
|
|
| Free Cash Flow | |||||||||||||
| Free Cash Flow |
23 726
N/A
|
22 026
-7%
|
23 142
+5%
|
(1 349)
N/A
|
9 059
N/A
|
21 866
+141%
|
40 009
+83%
|
49 158
+23%
|
17 998
-63%
|
8 410
-53%
|
12 030
+43%
|
18 472
+54%
|
|
Switch to:
Switch to:
See Also
Discover More
